Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01631994 · ClinicalTrials.gov registry record · NA
Study to Evaluate the Efficacy of Oral Dissolving Metoclopramide Before Video Capsule Endoscopy
A NA study, sponsored by Winthrop University Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT01631994 is a NA study that was terminated before completion, run by Winthrop University Hospital. The registered enrollment target is 6 participants.
The verdict
NCT01631994, a NA study, was terminated before completion, sponsored by Winthrop University Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Summary: This study investigates the use of oral dissolving metoclopramide during standard video capsule endoscopy. Metoclopramide is a pro -motility agent, that is, this medication helps with movement through the stomach and small bowel. This study will help us determine the effectiveness of oral dissolving metoclopramide on transit time through the stomach and small bowel of the video capsule that is ingested. This study may help with better diagnoses of pathology in the small bowel. Each patient enrolled in the study will either be assigned to a group that only ingests the capsule or the group that receives the oral dissolving metoclopramide plus capsule. Each patient will undergo the same standard procedures and precaution used during standard video capsule endoscopy. The patients that will qualify for the study are patients that are in need of video capsule endoscopy for further imaging of the small bowel. The patients must meet the inclusion criteria provided in the protocol and must not meet any of the exclusion criteria in the protocol. The hypothesis is that the patients that ingest the metoclopramide will have better capsule images and transit time and will allow for enhanced diagnosis of small bowel pathology.
Interventions
- DRUG metoclopramide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2011-09 |
| Est. Completion | 2015-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01631994
The ClinicalTrials.gov registry entry for NCT01631994 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Winthrop University Hospital, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which metoclopramide is the first listed.
NCT01631994 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01631994 about?
NCT01631994 is a clinical study titled "Study to Evaluate the Efficacy of Oral Dissolving Metoclopramide Before Video Capsule Endoscopy". Summary: This study investigates the use of oral dissolving metoclopramide during standard video capsule endoscopy. Metoclopramide is a pro -motility agent, that is, this medication helps with movement through the stomach and small bowel. This study will help us determine the effectiveness of oral ...
What is the current status of trial NCT01631994?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2011-09. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01631994?
The interventions under investigation include: metoclopramide (DRUG).
Who is sponsoring clinical trial NCT01631994?
This trial is sponsored by Winthrop University Hospital, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.